The cell signaling market is expected to reach USD 3.51 Billion by 2022 from USD 2.53 Billion in 2017, at a CAGR of 6.8%. Factors such as growth in biotech and biopharmaceuticals industries; increasing incidences of chronic diseases; technological advancements in cell-based research instruments, and rising government supports in the form of funds and grants for cell-based research activities are driving the growth of the market.
The market is fragmented in nature due to the presence of many large players. The prominent players in this market are Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.) (a subsidiary of Danaher Corporation), Bio-Rad Laboratories, Inc. (U.S.), PerkinElmer Inc. (U.S.), QIAGEN N.V. (Netherlands), Cell Signaling Technology, Inc. (U.S.), Promega Corporation (U.S.), Bio-Techne Corporation (U.S.), Abcam plc (U.K.), Miltenyi Biotec (Germany), Full Moon BioSystems, Inc. (U.S.), Cell Biolabs, Inc. (U.S.), Cisbio Bioassays (France), Rockland Immunochemicals Inc. (U.S.), BioVision, Inc. (U.S.), Tonbo Biosciences (U.S.), BPS Bioscience, Inc. (U.S.), StressMarq Biosciences Inc. (U.S.), Abeomics, Inc. (U.S.), Sino Biological, Inc. (U.S.), RayBiotech, Inc. (U.S.), MEDICAL & BIOLOGICAL LABORATORIES CO.,LTD. (Japan), and Santa Cruz Biotechnology, Inc. (U.S.).
Merck KGaA (Germany) held the leading position in the cell signaling market in 2016. The company focuses on acquisitions as its key strategy to exploit growth opportunities in the market. For instance, in November 2015, Merck KGaA completed acquisition of Sigma-Aldrich Corporation (U.S.) for USD 17.00 billion. This acquisition helped Merck KGaA to expand its life science research product portfolio around the world.
Thermo Fisher Scientific Inc. (U.S.) held the second position in the cell signaling market in 2016. The company focuses on expansion, acquisition, and product launches to maintain its leading position in the market. For instance, in September 2016, Thermo Fisher Scientific Inc. opened its new global headquarters at 168 Third Avenue in Waltham, Massachusetts (U.S.).
Becton, Dickson and Company (U.S.) was ranked third in the cell signaling Market in 2016. It focuses on expanding its presence in the market through product launches. For instance, in February 2016, Becton, Dickinson and Company launched the BD FACSymphony system, a novel cell analyzer which is specifically designed to measure up to 50 different characteristics of a single cell.
Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE